CMMB

Chemomab Therapeutics Ltd.NASDAQHealthcare

$1.56+6.41%ClosedMarket Cap: $9.6M

As of 2026-04-06

Analyst Consensus

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

Rating Distribution

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-08-27	Oppenheimer	maintain	Outperform	Outperform
2025-05-16	Oppenheimer	maintain	Outperform	Outperform

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.03	$36.2M	1
Sun Dec 31	$-0.04	$0.00	1
Mon Dec 31	$-0.20	$35.5M	1
Tue Dec 31	$0.00	$36.2M	0